3TC: combination trial stopped early as clinical benefit shown.
James
J S
JS
D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D016049:Didanosine / Q000008:administration & dosage / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D019259:Lamivudine; D010919:Placebos; D017211:Treatment Failure; D016047:Zalcitabine / Q000008:administration & dosage* / Q000627:therapeutic use; D015215:Zidovudine / Q000008:administration & dosage / Q000627:therapeutic use
D000998:Antiviral Agents; D010919:Placebos; D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine